In MDD patients, profound loss and reorganization of astrocytes lead to significant structural changes in the BBB, including approximately a 50% reduction in vascular coverage by astrocytic end-feet—particularly those immunoreactive to AQP4 in the orbitofrontal cortex—pointing to disruption of the neurovascular unit [47]. Here, AQP4 is linked to major depressive disorder.